![]() |
市場調查報告書
商品編碼
1684613
製藥機械市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測Pharmaceuticals Machinery Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球製藥機械市場價值為 252 億美元,並有望大幅成長,預計 2025 年至 2034 年期間的複合年成長率為 6.4%。這一強勁的成長軌跡受到全球對醫藥產品需求不斷成長的推動,人口老化、慢性病發病率不斷上升以及個人化醫療的日益普及推動。製造技術的進步,加上學名藥和疫苗生產的加速,進一步擴大了市場的潛力。不斷發展的生物製藥產業專注於生物製劑、生物相似藥和創新療法,也需要最先進的機器,為製造商創造有利可圖的機會。嚴格的監管要求必然需要先進的設備來確保精準度和合規性,而對製藥合約製造組織(CMO)的日益依賴是加速市場擴張的重要因素。
目前,藥品生產很大程度上依賴為滿足特定需求而量身訂製的尖端機械。生物製劑、疫苗和生物相似藥的生產需要專門的設備,例如高精度填充系統和無菌加工機械,以維持最高的品質和安全標準。 CMO 和合約開發和製造組織 (CDMO) 正在投資先進技術,確保它們能夠滿足多家製藥公司的大規模生產需求。此次合作進一步增強了產業能力,提高了生產效率和靈活性。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 252億美元 |
預測值 | 464億美元 |
複合年成長率 | 6.4% |
2024 年,固體劑量機領域將成為市場領導者,創收 96 億美元。預計 2025 年至 2034 年期間的複合年成長率為 6.8%。固體劑型,包括片劑、膠囊和粉末,是製藥業使用最廣泛的劑型,需要高效率、自動化和高速的機械。製造商越來越重視客製化和法規遵循性,以滿足特定的生產要求。此外,生物製劑和生物相似藥產量的不斷成長,也增加了對發酵槽、攪拌器和乾燥器等專用設備的需求,這些設備對於將活性藥物成分 (API) 轉化為成品至關重要。
全自動操作模式在 2024 年佔據了 61% 的市場佔有率,預計到 2034 年的複合年成長率為 6.6%。全自動機器簡化了藥品(包括藥片、膠囊和注射)的高速生產流程,管理了填充、封蓋、貼標和包裝等關鍵功能。這些機器滿足了生產對精度和效率日益成長的需求,確保了一致的品質並降低了錯誤率。半自動機器將自動化與人工監督相結合,為追求靈活性和效率的製造商提供了替代方案。
美國製藥機械市場規模在 2024 年達到 57 億美元,預計到 2034 年將以 6.5% 的複合年成長率成長。該地區的成長得益於對創新藥物的需求不斷增加、疫苗製造的進步以及對小批量和個人化藥物生產的關注。人口老化和慢性病發病率上升導致的醫療保健需求不斷成長,進一步凸顯了市場的不斷擴大。
The Global Pharmaceuticals Machinery Market was valued at USD 25.2 billion in 2024 and is poised for substantial growth, projected to expand at a CAGR of 6.4% between 2025 and 2034. This robust growth trajectory is fueled by the rising global demand for pharmaceutical products, driven by an aging population, the increasing prevalence of chronic diseases, and the growing adoption of personalized medicine. Advancements in manufacturing technologies, coupled with the accelerated production of generic drugs and vaccines, further amplify the market's potential. The evolving biopharmaceutical sector, with its focus on biologics, biosimilars, and innovative therapeutics, also demands state-of-the-art machinery, creating lucrative opportunities for manufacturers. Stringent regulatory requirements necessitate advanced equipment for precision and compliance, and the increasing reliance on pharmaceutical contract manufacturing organizations (CMOs) is an essential factor in accelerating market expansion.
Pharmaceutical production now relies heavily on cutting-edge machinery tailored to meet specific needs. The manufacturing of biologics, vaccines, and biosimilars requires specialized equipment, such as high-precision fill-finish systems and sterile processing machinery, to maintain the highest quality and safety standards. CMOs and contract development and manufacturing organizations (CDMOs) are investing in advanced technologies, ensuring they can meet large-scale production demands for multiple pharmaceutical companies. This collaboration further enhances the industry's capabilities, allowing for greater efficiency and flexibility in production.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $25.2 Billion |
Forecast Value | $46.4 Billion |
CAGR | 6.4% |
In 2024, the solid dosage machine segment emerged as the market leader, generating USD 9.6 billion. It is anticipated to grow at a CAGR of 6.8% between 2025 and 2034. Solid dosage forms, including tablets, capsules, and powders, are the most widely used in the pharmaceutical industry, necessitating highly efficient, automated, and high-speed machinery. Manufacturers increasingly prioritize customization and regulatory compliance to meet specific production requirements. Additionally, the growing production of biologics and biosimilars has increased the need for specialized equipment such as fermentation tanks, mixers, and dryers, critical in converting active pharmaceutical ingredients (APIs) into finished products.
The fully automatic operational mode accounted for 61% of the market share in 2024, with growth projected at a CAGR of 6.6% through 2034. Fully automatic machines streamline high-speed production processes for pharmaceuticals, including tablets, capsules, and injectables, managing critical functions such as filling, capping, labeling, and packaging. These machines address the rising demand for precision and efficiency in production, ensuring consistent quality and reduced error rates. Semi-automatic machines, blending automation with manual oversight, offer an alternative for manufacturers seeking flexibility and efficiency.
The US pharmaceuticals machinery market reached USD 5.7 billion in 2024 and is forecasted to grow at a CAGR of 6.5% through 2034. Growth in this region is driven by increasing demand for innovative drugs, advancements in vaccine manufacturing, and a focus on small-batch and personalized medicine production. Rising healthcare needs, fueled by an aging population and a higher prevalence of chronic conditions, further underscore the expanding market.